|
[1]
|
Casini, A., Neerman-Arbez, M., Ariëns, R.A. and de Moerloose, P. (2015) Dysfibrinogenemia: From Molecular Anomalies to Clinical Manifestations and Management. Journal of Thrombosis and Haemostasis, 13, 909-919. https://doi.org/10.1111/jth.12916
|
|
[2]
|
Casini, A. and de Moerloose, P. (2021) How I Treat Dysfibrinogenemia. Blood, 138, 2021-2030. https://doi.org/10.1182/blood.2020010116
|
|
[3]
|
Casini, A., Undas, A., Palla, R., Thachil, J. and de Moerloose, P. (2018) Diagnosis and Classification of Congenital Fibrinogen Disorders: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis, 16, 1887-1890. https://doi.org/10.1111/jth.14216
|
|
[4]
|
Casini, A., Blondon, M., Lebreton, A., Koegel, J., Tintillier, V., de Maistre, E., et al. (2015) Natural History of Patients with Congenital Dysfibrinogenemia. Blood, 125, 553-561. https://doi.org/10.1182/blood-2014-06-582866
|
|
[5]
|
Li, Y., Ding, B., Wang, X. and Ding, Q. (2022) Congenital (Hypo-)dysfibrinogenemia and Bleeding: A Systematic Literature Review. Thrombosis Research, 217, 36-47. https://doi.org/10.1016/j.thromres.2022.07.005
|
|
[6]
|
Zhou, J., Ding, Q., Chen, Y., Ouyang, Q., Jiang, L., Dai, J., et al. (2015) Clinical Features and Molecular Basis of 102 Chinese Patients with Congenital Dysfibrinogenemia. Blood Cells, Molecules, and Diseases, 55, 308-315. https://doi.org/10.1016/j.bcmd.2015.06.002
|
|
[7]
|
周礼扬, 丁秋兰. 遗传性异常纤维蛋白原血症的临床诊断与治疗进展[J]. 血栓与止血学, 2024, 30(1): 33-41.
|
|
[8]
|
Castaman, G., Giacomelli, S.H., Biasoli, C., Contino, L. and Radossi, P. (2019) Risk of Bleeding and Thrombosis in Inherited Qualitative Fibrinogen Disorders. European Journal of Haematology, 103, 379-384. https://doi.org/10.1111/ejh.13296
|